|
1.
|
Gragnoli C. Overweight condition and waist circumference and a candidate gene within the 12q24 locus. Cardiovasc Diabetol. 2013; 12:2.
|
|
|
|
|
2.
|
Gragnoli C. Proteasome modulator 9 and depression in type 2 diabetes. Curr Med Chem. 2012 Oct 1; 19(30):5178-80.
|
|
|
|
|
3.
|
Gragnoli C. Proteasome modulator 9 is linked to microvascular pathology of T2D. J Cell Physiol. 2012 Aug; 227(8):3116-8.
|
|
|
|
|
4.
|
Oberweis B, Gragnoli C. Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes. J Cell Physiol. 2012 Aug; 227(8):3001-6.
|
|
|
|
|
5.
|
Gragnoli C. Depression and type 2 diabetes: cortisol pathway implication and investigational needs. J Cell Physiol. 2012 Jun; 227(6):2318-22.
|
|
|
|
|
6.
|
Gragnoli C. Proteasome modulator 9 and carpal tunnel syndrome. Diabetes Res Clin Pract. 2011 Nov; 94(2):e47-9.
|
|
|
|
|
7.
|
Gragnoli C. Proteasome modulator 9 SNPs are linked to hypertension in type 2 diabetes families. Cardiovasc Diabetol. 2011; 10:77.
|
|
|
|
|
8.
|
Gragnoli C. PSMD9 is linked to type 2 diabetes neuropathy. J Diabetes Complications. 2011 Sep-Oct; 25(5):329-31.
|
|
|
|
|
9.
|
Gragnoli C. Proteasome modulator 9 gene is linked to diabetic and non-diabetic retinopathy in T2D. Ophthalmic Genet. 2011 Nov; 32(4):228-30.
|
|
|
|
|
10.
|
Gragnoli C. Hypercholesterolemia and a candidate gene within the 12q24 locus. Cardiovasc Diabetol. 2011; 10:38.
|
|
|
|
|
11.
|
Gragnoli C. Proteasome modulator 9 and macrovascular pathology of T2D. Cardiovasc Diabetol. 2011; 10:32.
|
|
|
|
|
12.
|
Gragnoli C. T2D-nephropathy linkage within 12q24 locus. Diabetes Res Clin Pract. 2011 Jun; 92(3):e73-5.
|
|
|
|
|
13.
|
Gragnoli C. PSMD9 is linked to MODY3. J Cell Physiol. 2010 Apr; 223(1):1-5.
|
|
|
|
|
14.
|
Gragnoli C. PSMD9 gene in the NIDDM2 locus is linked to type 2 diabetes in Italians. J Cell Physiol. 2010 Feb; 222(2):265-7.
|
|
|
|
|
15.
|
Meenakshisundaram R, Gragnoli C. CDK4 IVS4-nt40G-->A and T2D-associated obesity in Italians. J Cell Physiol. 2009 Nov; 221(2):273-5.
|
|
|
|
|
16.
|
Meenakshisundaram R, Piumelli N, Pierpaoli L, Gragnoli C. CDK4 IVS4-nt40G-->A SNP and type 2 diabetes in Italians. Diabetes Res Clin Pract. 2009 Nov; 86(2):e28-30.
|
|
|
|
|
17.
|
Meenakshisundaram R, Piumelli N, Pierpaoli L, Gragnoli C. CHOP 5'UTR-c.279T>C and +nt30C>T variants are not associated with overweight condition or with tumors/cancer in Italians - a case-control study. J Exp Clin Cancer Res. 2009; 28:90.
|
|
|
|
|
18.
|
Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg. 2009 Sep; 19(9):1333-4.
|
|
|
|
|
19.
|
Meenakshisundaram R, Gragnoli C. CDK4 IVS4-nt40 AA genotype and obesity-associated tumors/cancer in Italians - a case-control study. J Exp Clin Cancer Res. 2009; 28:42.
|
|
|
|
|
20.
|
Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. 2008 Dec; 217(3):605-17.
|
|
|
|
|
21.
|
Jonnakuty C, Gragnoli C. What do we know about serotonin? J Cell Physiol. 2008 Nov; 217(2):301-6.
|
|
|
|
|
22.
|
Gragnoli C. CHOP T/C and C/T haplotypes contribute to early-onset type 2 diabetes in Italians. J Cell Physiol. 2008 Nov; 217(2):291-5.
|
|
|
|
|
23.
|
Spanakis E, Gragnoli C. Bariatric surgery, safety and type 2 diabetes. Obes Surg. 2009 Mar; 19(3):363-8.
|
|
|
|
|
24.
|
Gragnoli C. The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid beta cell model for in vitro studies. J Cell Physiol. 2008 Aug; 216(2):569-70.
|
|
|
|
|
25.
|
Jonnakuty C, Gragnoli C. Karyotype of the human insulinoma CM cell line--beta cell model in vitro? J Cell Physiol. 2007 Dec; 213(3):661-2.
|
|
|
|
|
26.
|
Gragnoli C, Pierpaoli L, Piumelli N, Chiaramonte F. Linkage studies for T2D in Chop and C/EBPbeta chromosomal regions in Italians. J Cell Physiol. 2007 Nov; 213(2):552-5.
|
|
|
|
|
27.
|
Gragnoli C, Cronsell J. PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes. J Cell Physiol. 2007 Sep; 212(3):568-71.
|
|
|
|
|
28.
|
Gragnoli C, Cronsell J. Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population. Minerva Med. 2007 Jun; 98(3):163-6.
|
|
|
|
|
29.
|
Milord E, Gragnoli C. NEUROG3 variants and type 2 diabetes in Italians. Minerva Med. 2006 Oct; 97(5):373-8.
|
|
|
|
|
30.
|
Gragnoli C, Stanojevic V, Gorini A, Von Preussenthal GM, Thomas MK, Habener JF. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes. Metabolism. 2005 Aug; 54(8):983-8.
|
|
|
|
|
31.
|
Gragnoli C, Gragnoli C, Milord E, Habener JF. Linkage study of the glucagon receptor gene with type 2 diabetes mellitus in Italians. Metabolism. 2005 Jun; 54(6):786-7.
|
|
|
|
|
32.
|
Gragnoli C, Menzinger Von Preussenthal G, Habener JF. Triple genetic variation in the HNF-4alpha gene is associated with early-onset type 2 diabetes mellitus in a philippino family. Metabolism. 2004 Aug; 53(8):959-63.
|
|
|
|
|
33.
|
Gragnoli C, Cockburn BN, Chiaramonte F, Gorini A, Marietti G, Marozzi G, Signorini AM. Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. Diabetologia. 2001 Oct; 44(10):1326-9.
|
|
|
|
|
34.
|
Godart F, Bellanné-Chantelot C, Clauin S, Gragnoli C, Abderrahmani A, Blanché H, Boutin P, Chèvre JC, Froguel P, Bailleul B. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1alpha (TCF1) promoter region in MODY patients. Hum Mutat. 2000; 15(2):173-80.
|
|
|
|
|
35.
|
Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes. 1997 Oct; 46(10):1648-51.
|
|
|
|
|
36.
|
Lindner T, Gragnoli C, Furuta H, Cockburn BN, Petzold C, Rietzsch H, Weiss U, Schulze J, Bell GI. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene. J Clin Invest. 1997 Sep 15; 100(6):1400-5.
|
|
|
|
|
37.
|
Lindner T, Gragnoli C, Schulze J, Rietzsch H, Petzold C, Schröder HE, Cox NJ, Bell GI. The 31-cM region of chromosome 11 including the obesity gene tubby and ATP-sensitive potassium channel genes, SUR1 and Kir6.2, does not contain a major susceptibility locus for NIDDM in 127 non-Hispanic white affected sibships. Diabetes. 1997 Jul; 46(7):1227-9.
|
|
|
|
|
38.
|
Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG, Boccuni ML, Fava D, Gragnoli C, Andreani D, et al. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study). Diabetologia. 1995 Jul; 38(7):848-52.
|
|
|
|
|
39.
|
Pozzilli P, Buzzetti R, Giovannini C, Gragnoli C, Leslie RD. New and old trends for treating organ-specific autoimmune endocrinopathies. J Endocrinol. 1995 May; 145(2):195-9.
|
|
|
|
|
40.
|
Baroni MG, Alcolado JC, Gragnoli C, Franciosi AM, Cavallo MG, Fiore V, Pozzilli P, Galton DJ. Affected sib-pair analysis of the GLUT1 glucose transporter gene locus in non-insulin-dependent diabetes mellitus (NIDDM): evidence for no linkage. Hum Genet. 1994 Jun; 93(6):675-80.
|
|
|
|